Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot ...

A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

This year’s most innovative smaller companies prove that head count doesn’t cap ambition. These Small and Mighty standouts (51 to 200 employees) are thinking well beyond their ...

The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

A cheap home DNA kit seemed like a bit of fun – until the results exposed hidden ancestry and a family secret no one had prepared for.